Business news, event reports and more from Cellusion PR team

BIO International Conference 2023 Participation Report


Cellusion CEO, Dr. Hatou gave a company presentation at the BIO International Convention 2023 in Boston, on the status of development, including the progress of its lead program CLS001, First-in-Human investigator initiated clinical trial.

It was also a valuable opportunity to accelerate the international expansion of the business through meetings with stakeholders at the forefront of the bio-industry.

Back to the List